
The study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.14 per cent) had antibodies against SARS-CoV-2.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39ELkQT
via
IFTTT
0 comments:
Post a Comment